A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome**
References (45)
- et al.
Chronic fatigue syndrome: clinical condition associated with immune activation
Lancet
(1991) - et al.
Human herpesvirus 6 and myalgic encephalomyelitis
Lancet
(1988) - et al.
Allergy and the chronic fatigue syndrome
J Allergy Clin Immunol
(1988) A clinical and laboratory profile of symptomatic women with silicone breast implants
- et al.
Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation
Clin Psychol Rev
(1988) A rating instrument for anxiety disorders
Psychosomatics
(1971)- et al.
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syn-drome
Cytokine
(1991) - et al.
Chronic fatigue: Risk factors for symp-tom persistence in a 2 1/2-year follow-up study
Am J Med
(1995) The chronic fatigue syndrome
Am J Med
(1991)Part III: Viral studies of chronic fatigue syndrome. Introduction
Clin Infect Dis
(1994)
Naloxone *reversible monocyte dysfunction in patients with chronic fatigue syndrome
Scand J Immunol
Review of laboratory findings for patients with chronic fatigue syndrome
Rev Infect Dis
A comprehensive immunological analysis in chronic fatigue syndrome
Scand J Immunol
Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression
Clin Infect Dis
Immunologic abnormalities in chronic fatigue syndrome
J Clin Microbiol
A cluster of patients with a chronic mononudeosis-like syndrome
JAMA
Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome
Rev Infect Dis
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection
Ann Intern Med
Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies
Ann Intern Med
Brucellosis in the United States
Am J Public Health
Medical Aspects of delayed convalescence
Arch Intern Med
Studies on enterovirus in patients with chronic fatigue syndrome
Clin Infect Dis
Cited by (77)
Inflammatory proteins are altered in chronic fatigue syndrome—A systematic review and meta-analysis
2019, Neuroscience and Biobehavioral ReviewsChronic Fatigue Syndrome
2017, Principles and Practice of Pediatric Infectious DiseasesChronic fatigue syndrome and circulating cytokines: A systematic review
2015, Brain, Behavior, and ImmunityChronic coinfections in patients diagnosed with chronic lyme disease: A systematic review
2014, American Journal of MedicineCitation Excerpt :The literature search did not yield evidence of cryptic babesiosis resulting in a less overt syndrome. A study of patients with chronic fatigue syndrome found seroreactivity to Babesia microti in 2 controls but not in any of the study subjects with chronic fatigue.24 A case series of 3 patients attributed panic attacks to infection with multiple tick-borne pathogens including babesiosis.25
Chronic fatigue syndrome
2013, Handbook of Clinical NeurologyCitation Excerpt :A number of retrospective studies investigated the possible role of herpesviruses including Epstein−Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus 6 (HHV6); enteroviruses − largely Coxsackie B; retroviruses such as human T-cell leukemia virus type 2 (HTLV-2) and the spumaviruses; Borrelia burgdorferi and Borna disease virus. Although some studies reported elevated levels of viral antibodies in groups of CFS patients, the results were inconsistent and there was often considerable overlap between CFS patients and controls (Hotchin et al., 1989; Landay et al., 1991; Kawai and Kawai, 1992; Ablashi, 1994; Levy, 1994; MacDonald et al., 1996). A more definitive large study which tested for antibodies to 13 viruses found that none of these could either discriminate CFS patients from healthy controls, or CFS patients who reported a viral onset from those who did not (Buchwald et al., 1996).
Chronic Fatigue Syndrome
2012, Principles and Practice of Pediatric Infectious Diseases, Fourth Edition
- **
Cytokine testing was supported in part through funding from the National Institute of Allergy and Infectious Disease. Antibody testing for Babesia microti was supported in part by Public Health Service grants Al32403, Al-30548, and AR-41497 from the National Institutes of Health and grant U50/CCUS10343 from the Centers for Disease Control and Prevention.